Frontlight ResearchEarly access
Trial site
CHRU de Lille - Hôpital Salengro
- 2closed trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- COPD1 trial
- Parkinson disease1 trial
- Phase
- Phase 21 trial
- Phase 41 trial
- Status
- Completed2 trials
- Lead sponsor
- Assistance Publique Hopitaux De Paris1 trial
- Il-Yang Pharm. Co., Ltd.1 trial
Closed trials
Completed
Active, not recruiting
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026